CL2017001064A1 - Composición que comprende oligosacáridos dependientes de fut2 y lacto-n-neotetraosa para usar en la promoción del desarrollo del cerebro y de la cognición. - Google Patents

Composición que comprende oligosacáridos dependientes de fut2 y lacto-n-neotetraosa para usar en la promoción del desarrollo del cerebro y de la cognición.

Info

Publication number
CL2017001064A1
CL2017001064A1 CL2017001064A CL2017001064A CL2017001064A1 CL 2017001064 A1 CL2017001064 A1 CL 2017001064A1 CL 2017001064 A CL2017001064 A CL 2017001064A CL 2017001064 A CL2017001064 A CL 2017001064A CL 2017001064 A1 CL2017001064 A1 CL 2017001064A1
Authority
CL
Chile
Prior art keywords
fut2
lacto
olig2
neotetraose
cognition
Prior art date
Application number
CL2017001064A
Other languages
English (en)
Inventor
Norbert Sprenger
Sagar Thakkar
Castro Carlos Antonio De
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2017001064A1 publication Critical patent/CL2017001064A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides
    • A23V2250/284—Oligosaccharides, non digestible

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)

Abstract

<p>ESTA INVENCIÓN SE RELACIONA CON EL USO DE UNA COMPOSICIÓN NUTRICIONAL QUE COMPRENDE OLIGOSACÁRIDOS DEPENDIENTES DE FUT2 PARA PROMOVER EL CRECIMIENTO Y DESARROLLO DEL CEREBRO EN INFANTES EN EL PERIODO POSTNATAL MUY TEMPRANO. LA COMPOSICIÓN NUTRICIONAL COMPRENDE OLIGOSACARIDOS DEPENDIENTES DE FUT2 Y LACTO-N-NEOTETRAOSA Y ES PARA USAR ESPECÍFICAMENTE EN LA PROMOCIÓN DEL CRECIMIENTO DE RECUPERACIÓN DEL CEREBRO EN INFANTES PREMATUROS O EN INFANTES CON BAJO PESO DE NACIMIENTO. LA INVENCIÓN SE RELACIONA, ADEMÁS, CON UN KIT QUE COMPRENDE AL MENOS DOS DE ESTAS COMPOSICIONES NUTRICIONALES.</p>
CL2017001064A 2014-10-31 2017-04-28 Composición que comprende oligosacáridos dependientes de fut2 y lacto-n-neotetraosa para usar en la promoción del desarrollo del cerebro y de la cognición. CL2017001064A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14191277 2014-10-31

Publications (1)

Publication Number Publication Date
CL2017001064A1 true CL2017001064A1 (es) 2018-01-26

Family

ID=51932178

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001064A CL2017001064A1 (es) 2014-10-31 2017-04-28 Composición que comprende oligosacáridos dependientes de fut2 y lacto-n-neotetraosa para usar en la promoción del desarrollo del cerebro y de la cognición.

Country Status (11)

Country Link
US (2) US10328091B2 (es)
EP (1) EP3212012A1 (es)
CN (1) CN107105741A (es)
AU (1) AU2015340652B9 (es)
BR (1) BR112017007375A2 (es)
CL (1) CL2017001064A1 (es)
MX (1) MX374422B (es)
MY (1) MY182925A (es)
PH (1) PH12017500387A1 (es)
RU (1) RU2720933C2 (es)
WO (1) WO2016066735A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015340652B9 (en) * 2014-10-31 2020-04-16 Société des Produits Nestlé S.A. Composition comprising Fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
CN107846957A (zh) * 2015-03-05 2018-03-27 雀巢产品技术援助有限公司 用于改善婴儿或幼儿粪便稠度或频率的组合物
MX2018015187A (es) * 2016-08-04 2019-04-24 Nestec Sa Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
ES3055329T3 (en) 2017-12-21 2026-02-11 Nestle Sa Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility
WO2020001862A1 (en) * 2018-06-25 2020-01-02 Societe Des Produits Nestle S.A. Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
WO2020001863A1 (en) * 2018-06-25 2020-01-02 Societe Des Produits Nestle S.A. Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system
US11849747B1 (en) * 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
EP4255198A1 (en) * 2020-12-04 2023-10-11 Société des Produits Nestlé S.A. Stable aqueous composition for preterm to promote early postnal growth
EP4346450B1 (en) * 2021-06-04 2025-02-26 N.V. Nutricia Infant formula for feeding infants receiving infant formula and human breast milk
CN115399480A (zh) * 2021-09-26 2022-11-29 黑龙江飞鹤乳业有限公司 含泛酸的促神经发育营养组合物及其制备和应用
CN115644458A (zh) * 2022-10-26 2023-01-31 君乐宝乳业集团有限公司 促进体格发育的营养组合物、其制备方法及其应用
WO2024223917A1 (en) * 2023-04-28 2024-10-31 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in a subject to support brain development and/or cognitive development
WO2025027192A1 (en) * 2023-08-03 2025-02-06 Mjn U.S. Holdings Llc Human milk fortifier micronutrient supplementation kit
CN121712403A (zh) * 2023-08-29 2026-03-20 雀巢产品有限公司 用于个体以支持脑发育和/或视力发育的包含人乳低聚糖的组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US7158474B1 (en) * 2001-02-21 2007-01-02 At&T Corp. Interference suppressing OFDM system for wireless communications
EP2493336A1 (en) * 2009-10-29 2012-09-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
EP2767173A1 (en) 2010-04-27 2014-08-20 N.V. Nutricia Use of human milk oligosaccharides in infant nutrition
EP2465509A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
CA2822219C (en) * 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
EP2522232A1 (en) * 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
NL2007268C2 (en) * 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
ES2601891T3 (es) * 2011-10-18 2017-02-16 Nestec S.A. Composición para su uso en crecimiento cerebral y/o desarrollo cognitivo y/o psicomotor
EP3111942B1 (en) * 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
AU2015340652B9 (en) * 2014-10-31 2020-04-16 Société des Produits Nestlé S.A. Composition comprising Fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
CN107404925A (zh) * 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿胃肠感染/炎症的组合物
CN107846957A (zh) * 2015-03-05 2018-03-27 雀巢产品技术援助有限公司 用于改善婴儿或幼儿粪便稠度或频率的组合物
CN107427054A (zh) * 2015-03-05 2017-12-01 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
ES2772685T3 (es) * 2015-08-04 2020-07-08 Nestle Sa Composiciones nutricionales con 2FL y LNNT para inducir una microbiota intestinal similar a la de los bebés lactantes

Also Published As

Publication number Publication date
BR112017007375A2 (pt) 2017-12-19
AU2015340652B9 (en) 2020-04-16
EP3212012A1 (en) 2017-09-06
US10328091B2 (en) 2019-06-25
AU2015340652A1 (en) 2017-03-23
MX374422B (es) 2025-03-06
US20170333462A1 (en) 2017-11-23
AU2015340652B2 (en) 2020-02-20
US20190269710A1 (en) 2019-09-05
WO2016066735A1 (en) 2016-05-06
RU2017118533A (ru) 2018-12-03
US10821125B2 (en) 2020-11-03
RU2017118533A3 (es) 2019-04-12
MY182925A (en) 2021-02-05
CN107105741A (zh) 2017-08-29
RU2720933C2 (ru) 2020-05-14
PH12017500387A1 (en) 2017-07-17
MX2017005561A (es) 2017-06-23

Similar Documents

Publication Publication Date Title
CL2017001064A1 (es) Composición que comprende oligosacáridos dependientes de fut2 y lacto-n-neotetraosa para usar en la promoción del desarrollo del cerebro y de la cognición.
CL2017000086A1 (es) Granos cerámicos y métodos para su producción
CL2017002445A1 (es) Variantes de pertuzumab y su evaluación.
SV2017005367A (es) Composiciones y métodos de uso para tratar trastornos metabólicos
CL2017003402A1 (es) Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
CL2017001046A1 (es) Inhibidoes del bromodominio
BR112017018368A2 (pt) composições contendo rna para o tratamento de doenças tumorais
GT201400283A (es) Formas cristalinas de un modulador del receptor androgénico
CL2017000111A1 (es) Moléculas con especificidad para cd45 y cd79
PT3215133T (pt) Métodos e composições relacionados com a utilização de tensioativos de baixo hlb na produção de nanotransportadores sintéticos que compreendem um rapalog
MX2017004761A (es) Uso de cannabinoides en el tratamiento de enfermedades degenerativas del musculo esqueletico.
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
CL2017001438A1 (es) Antagonistas de miostatina o activina para el tratamiento de sarcopenia
MX2016011176A (es) Polipeptidos fhbp meningococicos modificados.
CL2017000136A1 (es) Composiciones de azúcar para la formación de comprimidos por compresión directa
BR112017001712A2 (pt) sistema de nutrição ótimo para os períodos de preconcepção/pré-natal/pós-natal, composições e kits para uso dos mesmos e métodos para fabricação e uso dos mesmos
CL2020000812A1 (es) Semaglutida en la terapia médica.
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
MX384131B (es) Compuestos neurotransmisores de dihidroxifenilo, composiciones y métodos.
CR20170090A (es) Derivados de terahidroquinolina como inhibidores del bromodominio
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
AR113514A1 (es) Composiciones y métodos para mejorar la utilización del fósforo y el calcio en la dieta de los animales
AR103756A1 (es) Jarabes de alulosa
DOP2020000104A (es) Métodos de uso y composiciones que contienen dulaglutida